H
Power Law company profile
Humacyte
Biotech & Life Sciences · Durham, United States · Founded 2004 Unicorn
Valuation
$196M
Market cap · Apr/2026
Revenue
$2.0M
Latest reported FY
Global footprint
Where Humacyte has talent and traffic
Web traffic by country
12K
monthly visits
across markets
across markets
🇺🇸 United States41.7%
🇨🇦 Canada20%
🇦🇺 Australia18.3%
🇪🇸 Spain9.2%
🇩🇪 Germany6.7%
Patent intelligence
$25M patent portfolio · 18 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$25M
12.9% of market cap · 16.1× smaller than top peer NovoCure ($409M)
18 active patent families
Where Humacyte innovates
Biomedical engineeringTissue engineeredBiologyBioreactorStent
Below peer median on Strategic
Quality vs same-sector peers
Humacyte on the five Patsnap quality dimensions
Humacyte in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Humacyte concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Humacyte and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Humacyte on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.